APOLIPOPROTEIN GENOTYPE - ANVISA Registration 10338930333
Access comprehensive regulatory information for APOLIPOPROTEIN GENOTYPE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10338930333 and manufactured by EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until Aug 11, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
10338930333
25351084746202575
93741726000166
Company Information
Dates and Status
Aug 11, 2025
11/08/2035
09/18/2025 19:00:01
APOLIPOPROTEIN E
Apolipoprotein E Assay Kit (Apo E)
BEIJING STRONG BIOTECHNOLOGIES, INC.
80464810870
Jan 02, 2024
LIPOPROTEIN
N APO E
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
10345161076
May 04, 2009
APOLIPOPROTEIN A
Preciset Lp(a) Gen.2
ROCHE DIAGNOSTICS GMBH
10287411034
Dec 30, 2013
APOLIPOPROTEIN A
PreciControl Lp(a) Gen. 2
ROCHE DIAGNOSTICS GMBH
10287411033
Dec 30, 2013
APOLIPOPROTEIN A-II
N APO II
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
10345161142
Aug 10, 2009